{"type":"post","id":"anthropic-reports-early-progress-using-claude-in-drug-e3a07b","slug":"anthropic-reports-early-progress-using-claude-in-drug-e3a07b","title":"Anthropic reports early progress using Claude in drug development with six partner organizations","description":"Anthropic has published early case studies from six drug-development partnerships using Claude, alongside its own discovery programs.","retrieval_nugget":"Anthropic has published early case studies from six drug-development partnerships using Claude, alongside its own discovery programs. The significance for AI builders is not a claim of autonomous science: the report describes systems tied to lab data, document repositories, experiments, and human review, with measured but still preliminary results.","published_at":"2026-10-27","updated_at":"2026-10-27","record_date":"2026-10-27","date_kind":"published_at","topics":["claude","anthropic","claude-code"],"entities":["Anthropic","Claude","Claude Code","BigHat Biosciences","Divergence Labs","Enveda","Generate Biomedicines","The Column Group"],"related_patterns":[],"novelty_label":"new_fact","what_changed":"Anthropic now reports six drug-development research partnerships and its own rare-disease discovery efforts, including Claude handling much of the scientific and operational work.","prior_refs":["memory:cc1176ce-796f-8507-ac47-153cab59397f","memory:5198c94d-4ea5-8aba-a911-3197f4406648"],"source_url":"https://www.anthropic.com/research/early-progress-drug-development","source_urls":["https://www.anthropic.com/research/early-progress-drug-development"],"schema_version":"newruntime-agent-readable-v0.2","stable_id":"post:anthropic-reports-early-progress-using-claude-in-drug-e3a07b","status":"published","visuals":[],"editor":{"role":"editor","name":"Andrey Reshetnikov","profile":"https://newruntime.com/owner-profile.md","profile_json":"https://newruntime.com/owner-profile.json","same_as":["https://www.linkedin.com/in/reshetnikov1/","https://t.me/lapetuse"]},"routes":{"html":"https://newruntime.com/posts/anthropic-reports-early-progress-using-claude-in-drug-e3a07b/","markdown":"https://newruntime.com/posts/anthropic-reports-early-progress-using-claude-in-drug-e3a07b.md","json":"https://newruntime.com/posts/anthropic-reports-early-progress-using-claude-in-drug-e3a07b.json"},"next_reads":[{"type":"topic","path":"/topics/claude/","url":"https://newruntime.com/topics/claude/","title":"Claude","reason":"Explore the claude topic hub.","media_type":"text/html","markdown_url":"https://newruntime.com/topics/claude.md","json_url":"https://newruntime.com/topics/claude.json"},{"type":"topic","path":"/topics/anthropic/","url":"https://newruntime.com/topics/anthropic/","title":"Anthropic","reason":"Explore the anthropic topic hub.","media_type":"text/html","markdown_url":"https://newruntime.com/topics/anthropic.md","json_url":"https://newruntime.com/topics/anthropic.json"},{"type":"topic","path":"/topics/claude-code/","url":"https://newruntime.com/topics/claude-code/","title":"Claude Code","reason":"Explore the claude-code topic hub.","media_type":"text/html","markdown_url":"https://newruntime.com/topics/claude-code.md","json_url":"https://newruntime.com/topics/claude-code.json"},{"type":"collection","path":"/posts/","url":"https://newruntime.com/posts/","title":"Field Notes","reason":"Open the latest editorial analysis.","media_type":"text/html","json_url":"https://newruntime.com/posts.json"},{"type":"collection","path":"/source-ledger.json","url":"https://newruntime.com/source-ledger.json","title":"Source Ledger","reason":"Inspect the public source evidence graph.","media_type":"application/json"}]}